FDA Cleared New Catheter System for Stroke Access

The device is designed to help surgeons navigate complex neurovascular anatomy during procedures.

Updated on Sept. 28, 2026 in Stroke

Isometric editorial illustration showing a sleek, metallic medical catheter with a coiled flexible tip on a sterile tray.
The FDA cleared the FreeClimb 46 and Tenzing 4 catheter system, providing surgeons with new tools to navigate complex neurovascular anatomy for stroke treatment. AI Illustration. Upload story photo >

Live Poll

Do you believe new medical technology typically leads to better health outcomes for patients?

The FDA granted 510(k) clearance to the FreeClimb 46 catheter and Tenzing 4 system for use in neurovascular procedures. This integrated technology provides tools for accessing difficult areas of the brain to support stroke treatment.

Why it matters

Improving the maneuverability of surgical tools in distal and narrow anatomy can enhance the precision of neurovascular interventions. The clearance introduces a new option for clinicians performing procedures in small, hard-to-reach blood vessels.

The FDA granted 510(k) clearance for the FreeClimb 46 and Tenzing 4 system, which incorporates a proprietary Monopoint single-operator technology. While the company holds 200 issued patents for its neurovascular platform, large-scale clinical trial performance data is still emerging.

The players

Route 92 Medical

A medical device company based in West Jordan, Utah, that specializes in neurovascular access technologies.

FDA

The federal agency responsible for regulating medical devices and ensuring their safety and effectiveness.

The details

The FreeClimb 46 and Tenzing 4 operate as an integrated neurovascular access system. The Tenzing delivery catheters are specifically engineered to navigate through challenging neurovascular anatomy using a Monopoint single-operator design. This approach facilitates access to smaller and more distal vessels that are often difficult to reach during urgent medical interventions.

Timeline

  1. September 28, 2026: FDA clearance for the system was announced.

Health Landscape

This clearance follows the standard regulatory path established by the FDA 510(k) medical device clearance pathway. It represents a continuation of industry efforts to refine neurovascular access tools to treat strokes in increasingly distal regions of the brain.

This technology is used by specialists during neurovascular procedures in hospital settings. If you or a loved one are facing a procedure involving complex vascular anatomy, it is worth discussing the specific access tools and systems your surgeon intends to use with your medical team.

The takeaway

Advancements in catheter design aim to make delicate brain procedures safer by improving navigation in narrow vessels. Patients or families should feel empowered to ask their neurovascular surgeon about the type of access systems used to ensure the best possible approach for their specific anatomy.

Further reading

For more information on the latest developments in acute care, visit Stroke.

More information

Find further company details and information on their current neurovascular technology at the Route 92 Medical company portal.

Live Poll

Do you believe new medical technology typically leads to better health outcomes for patients?